Star Combo Pharma Limited

Equities

S66

AU0000004798

Other Specialty Retailers

Delayed Australian S.E. 08:08:45 2024-05-02 pm EDT 5-day change 1st Jan Change
0.125 AUD +4.17% Intraday chart for Star Combo Pharma Limited 0.00% -13.79%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
An unknown buyer acquired 49% stake in Austoyou Group Pty Ltd and Koala Mall Pty Ltd from Star Combo Pharma Limited. CI
Star Combo Pharma Limited Announces Resignation of Ziye Sui as Non- Executive Director CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Star Combo Pharma Issues Shares to Vietnamese Distributor MT
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Star Combo Pharma Limited Announces Group Revenue Results for the Second Quarter Ended 31 December 2021 CI
Star Combo Pharma Limited Announces Supplementary Announcement on New Contract CI
Australian Shares Extend Gains as IT, Financial Counters Offset Losses in Energy MT
Star Combo Pharma Secures Nearly $4 Million Order for Bulk Capsules MT
Star Combo Pharma Limited Receives $5.0 Million Order CI
Star Combo Pharma : Signs Deal for Health Supplement Distribution to Vietnam MT
Star Combo Signs 12-Month Exclusive Distribution Agreement with Happy Co. Ltd for Widespread Sales and Distribution of its Proprietary Health Supplement Product Line, Costar Across Vietnam CI
Star Combo Pharma : Secures Approval for New Research and Development Facility MT
Star Combo Pharma Limited Announces Development Application Approval Receives for R&D Facilities At Smithfield CI
Star Combo Pharma Limited Reports Earnings Results for the Half Year Ended December 31, 2020 CI
Star Combo Pharma : Fiscal Q2 Revenue Up 6% MT
Star Combo Pharma Limited Continues to Progress its Contract Manufacturing Expansion Strategy CI
Star Combo Pharma Limited Announces the Expansion of Its Manufacturing Capabilities At Its Wholly-Owned Tga-Licensed Nutraceutical Manufacturing Site CI
Star Combo Pharma Limited Reports Earnings Results for the Full Year Ended June 30, 2020 CI
Star Combo Pharma Limited Completes the Purchase of Land Located At 165 Woodpark Road, Smithfield, New South Wales CI
Star Combo Pharma Limited Expands Capacity - Milk Powder Blend and Pack Facility CI
Star Combo Pharma Limited Announces Board Changes CI
Chart Star Combo Pharma Limited
More charts
Star Combo Pharma Limited is an Australia-based company that is primarily engaged in the manufacture and distribution of health and natural beauty products. The Company operates through two segments: Star Combo business and Austoyou retail. The Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skincare products. The Austoyou retail business segment is made up of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd and Star Combo Australia Pty Ltd.
More about the company
  1. Stock Market
  2. Equities
  3. S66 Stock
  4. News Star Combo Pharma Limited
  5. Star Combo Pharma Secures Nearly $4 Million Order for Bulk Capsules